Atlas Trials

89Zr-atezolizumab PET Scan and Lobular Breast Cancer

Clinical trial NCT04222426 · TERMINATED

Trial details

NCT number
NCT04222426
Sponsor
University Medical Center Groningen
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Lobular Metastatic Breast Cancer
Start date
2019-12-18
Primary completion
2022-05-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.